As per DelveInsight’s assessment, the Global Bone Densitometers market was valued at USD 730.18 million in 2021 and growing at a CAGR of 4.15% during the forecast period (2022 to 2027); it is expected to reach USD 935.18 million by 2027. Some of the key factors such as the rising prevalence of osteoporosis across the globe, increasing prevalence of rheumatoid arthritis and cystic fibrosis, the growing burden of the elderly population, rising number of products specific to bone densitometers in development with the scope of entering the market are expected to drive the Global bone densitometers market in the coming years. Some of the key market players operating in the bone densitometers market include General Electric, Hologic Inc., Xingaoyi Medical Equipment, Swissray, Echolight, Eurotec Medical Systems, Trivitron Healthcare, BeamMed, Scanflex Healthcare AB, Medonica, OsteoSys Corp, CyberLogic, Oscare Medical Oy, L’Acn Srl., Shenzhen Xray Electric Co., YOZMA BMTech, Nanoomtech, FURUNO Electric, Osteometer MediTech, Inc. (OSI Systems, Inc.), Diagnostic Medical Systems Group, and others.
DelveInsight’s “Bone Densitometers Market Forecast 2027” research report provides the current and forecasted bone densitometers market size, share, and trends analysis for the next five years, upcoming innovations in the segment, and major market drivers & barriers. The report also covers an in-depth assessment of the key competitors and emerging products in the domain.
Bone Densitometers Market: Overview
A bone densitometer is an enhanced form of X-ray technology that is capable of measuring bone mineral density (BMD). The devices use small doses of ionizing radiation for producing images inside the body that involve the lower spine or hips for measuring bone loss.
To provide a better understanding of the market trends, the report covers the “Bone Densitometers Market” dynamics segmented by Technology (Axial Bone Densitometry [Central Dual-Energy X-Ray Absorptiometry (DEXA), Quantitative Computed Tomography (QCT)], Peripheral Bone Densitometry [Peripheral Dual-Energy X-Ray Absorptiometry (PDEXA), Peripheral Quantitative Computed Tomography (PQCT), Quantitative Ultrasound, Others]), by end-user (hospitals, diagnostic centers, others), and by geography.
As per DelveInsight’s assessment, in the product segment of the bone densitometers market, the Central Dual-Energy X-Ray Absorptiometry (DEXA) is estimated to hold the highest share in the coming years. DEXA is considered the gold standard for bone density analysis due to the benefits associated with the technology, such as the amount of radiation used in these systems being significantly lower than conventional X-rays and other radiographic technologies, thereby massively increasing their safety profile for repetitive scanning.
Bone Densitometers Market Analysis
The bone densitometers market is witnessing a growth in product demand owing to various reasons. The rising prevalence of osteoporosis is one of the key factors driving the demand for bone densitometers products, and it is considered a major global health problem. Worldwide, fractures tend to affect one in three women and one in five men over the age of 50. As per the International Osteoporosis Foundation 2021, in the year 2019, about 32 million individuals aged 50+ have been estimated to have osteoporosis across Europe (European Union, plus Switzerland and the United Kingdom), which is equivalent to 5.6% of the total European population aged 50+. Another key factor responsible for the increasing demand for bone densitometers is the rise in the geriatric population that is highly prone to osteoporosis and osteopenia disorders. Some of the key factors, such as the lack of awareness amongst people regarding bone densitometers and the high cost of procedures, are expected to hamper the bone densitometers market growth in the coming years.
Due to the Covid-19 outbreak, the bone densitometers market reported a setback in market growth for a short period of time. Policy measures adopted to slow the transmission of disease lead to a decrease in the demand for bone densitometers. Outpatient visits and the suspension of non-emergency hospitals and procedures lead to a reduced number of routine clinical examinations and related procedures. However, with the active vaccination and slower transmission of Covid-19, the situation is improving, which is expected to uplift the bone densitometers products demand and the market growth in the coming years.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight into Bone Densitometers Types and Emerging Products
Bone Densitometers Market – Global Market Assessment and Forecast
Among all the regions, North America is expected to account for the largest share in the global bone densitometers market. The growing prevalence of osteoporosis is expected to drive the bone densitometers demand in the region in the coming years. Moreover, supportive government policies promoting proper management of osteoporosis and increasing sedentary lifestyles, amongst others, are also anticipated to drive market growth. The active presence of major MedTech giants such as General Electric Company, Hologic, Inc., and OSI Systems, Inc., amongst others, and the launch of new and innovative products, will further boost the North American bone densitometers market.
Interested in knowing how the market will grow by 2027? Click to get a snapshot of Bone Densitometers Market Trends and Developments
Bone Densitometers Market – Key Developments and Breakthroughs
Over the years, the bone densitometers market has evolved significantly owing to the active participation of global MedTech companies and technological advancements in the domain.
Some of the major advancements in the Bone Densitometers Market in recent years are –
- On June 16, 2021, Echolight officially landed in India by signing a commercial agreement with an important local partner in Chandigarh, in the north of India for the distribution of the entire range of products throughout the Indian territory.
- On May 30, 2019, Hologic announced its partnership with DEXA+ to distribute the DXA system for body composition measurement. The Partnership allowed Hologic to expand its expertise in body composition assessment and the reach of its market-leading DXA system.
As per DelveInsight, the ongoing clinical & commercial development activities and research in the domain will contribute immensely to the bone densitometers market growth in the coming years.
Learn more about the ongoing development in the market @ Bone Densitometers Market – Clinical and Commercial Development Activities
Key Companies in the Bone Densitometers Market
Some of the major MedTech players operating in the bone densitometers market include General Electric, Hologic Inc., Xingaoyi Medical Equipment Co. Ltd., Swissray, Echolight S.p.a, Eurotec Medical Systems srl, Trivitron Healthcare, BeamMed Ltd., Scanflex Healthcare AB, Medonica Co. LTD, OsteoSys Corp, CyberLogic, Inc., Oscare Medical Oy, L’Acn Srl., Shenzhen Xray Electric Co., Ltd., YOZMA BMTech Co., Ltd., Nanoomtech Co., Ltd., FURUNO Electric Co., Ltd., Osteometer MediTech, Inc. (OSI Systems, Inc.), Diagnostic Medical Systems Group, and others.
As per DelveInsight, due to the very high growth rate and positive return, several new players are expected to enter the bone densitometers market in the coming years. The entry of new players and the launch of emerging products will immensely drive market growth.
Learn how new players’ entries will transform the market dynamics in the coming years @
Bone Densitometers Market Trends and Competitive Landscape
Scope of the Bone Densitometers Market Report:
- Study Period – 2019-2027
- Bone Densitometers Market Assessment –
- By Technology – Axial Bone Densitometry (Central Dual-Energy X-Ray Absorptiometry (DEXA), Quantitative Computed Tomography (QCT)), Peripheral Bone Densitometry (Peripheral Dual-Energy X-Ray Absorptiometry (pDEXA), Peripheral Quantitative Computed Tomography (pQCT), Quantitative Ultrasound, Others.
- By End-User – Hospitals, Diagnostic Centers, Others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
- Geography Covered – Global (North America, Europe, Asia-Pacific, and Rest of the World)
Table of Content
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Bone Densitometers Market Key factors analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Bone Densitometers Market |
| 7 | Bone Densitometers Market Layout |
| 8 | Global Company Share Analysis – Key 3–5 Companies |
| 9 | Product Profiles and Key Companies |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Reach out to us to get a more detailed overview of the Bone Densitometers Market Assessment and Forecast 2027
Related Report by DelveInsight
“Osteoporosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Osteoporosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key companies such as Shanghai JMT-Bio Inc., Transcenta Holding, Celltrion, Sandoz, Enzene Biosciences, Fresenius Kabi, Gedeon Richter, Samsung Bioepis, Alvotech, MAbxience, Shanghai Henlius Biotech, and others are actively working in the Osteoporosis Market.
Osteoporosis Epidemiology Forecast
“Osteoporosis – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Osteoporosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Osteoporosis Pipeline Insight, 2022
“Osteoporosis- Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in the Osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products.
Postmenopausal Osteoporosis Market
“PostMenopausal Osteoporosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the key companies in the market includes Sandoz, Haoma Medica, Amgen Inc., Clonz Biotech, Eli Lilly and Company, Enteris BioPharma, Ligand Pharmaceuticals Incorporated, Merck & Co., Inc, Outlook Therapeutics, Inc, and many others.
“Rheumatoid Arthritis Market Insights, Epidemiology and Market Forecast– 2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends in the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan. Some of the key companies in the market include R-Pharm, Taisho Pharmaceuticals, GlaxoSmithKline, Aclaris Therapeutics, Bristol Myers Squibb, Eli Lilly, Taiho Pharmaceutical, Cyxone, Gilead Sciences, Kiniksa Pharmaceuticals, Istesso, Applied Molecular Transport, Horizon Therapeutics, Genosco (Oscotec), Hope Biosciences, Abivax, Mesoblast, Pfizer, Akros Pharma/Japan Tobacco, Pfizer/Philogen, AbbVie, Pfizer, SynAct Pharma, and others.
“Cystic Fibrosis Market Insights, Epidemiology, and Market Forecast 2032” report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the Cystic Fibrosis market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Some of the key companies in the market include Verona Pharmaceuticals, Eloxx Pharmaceuticals, Inc., Vertex Pharmaceuticals, Santhera Pharmaceuticals, Laurent Pharmaceuticals Inc., Vertex Pharmaceuticals, and others.
Bone Grafts and Substitutes Market
Global Bone Grafts and Substitutes Market was valued at USD 3.20 billion in 2021, growing at a CAGR of 6.09% during the forecast period from 2022 to 2027 to reach USD 4.56 billion by 2027. Some of the key companies in the market includes Zimmer Biomet, DePuy Synthes (Johnson & Johnson), Smith & Nephew, Stryker, Nuvasive Inc, Baxter, AlloSource, Orthofix Medical Inc., Musculoskeletal Transplant Foundation, Bioventus, Exactech Inc, B. Braun Melsungen AG, SeaSpine, Medtronic, Dentsply Sirona Inc. Institut Straumann AG, SOUTHERN IMPLANTS, MedBone Biomaterials, BioHorizons, NORAKER and others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Learn How the MedTech Devices Market is evolving with the ongoing clinical and commercial developments in the domain: MedTech Market Outlook
Contact Us
Shruti Thakur
Manager (Marketing & Branding)
info@delveinsight.com
+1(919)321-6187